Prise en charge prophylactique, thérapeutique des complications infectieuses et vaccination des patients traités par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)-Reference-Cited by-同舟云学术

Prise en charge prophylactique, thérapeutique des complications infectieuses et vaccination des patients traités par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Published:2021-12 Issue:12 Volume:108 Page:S90-S97
ISSN:0007-4551
Container-title:Bulletin du Cancer
language:fr
Short-container-title:Bulletin du Cancer

Author:

Paul Franciane,Vicente Céline,Courbon Corinne,Moreau Anne-Sophie^ORCID,Picard Muriel,Pochon Cécile,Sterin Arthur,Tudesq Jean-Jacques^ORCID,Yakoub-Agha Mathilde,Bay Jacques-Olivier,Yakoub-Agha Ibrahim

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference29 articles.

1. Beginning the CAR T cell therapy revolution in the US and EU;Grupp;Curr Res Transl Med,2018

2. Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation;Kansagra;Biol Blood Marrow Transplant,2019

3. Tisagenlecleucel in adult relapsed or refractory diffuse large B-Cell lymphoma;Schuster;N Engl J Med,2019

4. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma;Neelapu;N Engl J Med,2017

5. Real world experience of approved chimeric antigen receptor T-cell therapies outside of clinical trials;Yassine;Curr Res Transl Med,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T cells for treating systemic lupus erythematosus: A promising emerging therapy;Joint Bone Spine;2024-09

2. Multiple myeloma and infections in the era of novel treatment modalities;Leukemia Research;2024-08

3. Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma;Frontiers in Oncology;2024-06-11

4. Pneumocystis pneumonia in French intensive care units in 2013–2019: mortality and immunocompromised conditions;Annals of Intensive Care;2024-05-22

5. Toxicités hématologiques après CAR-T cells, recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC);Bulletin du Cancer;2024-04